Stay updated on Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    No significant changes detected between the two screenshots; the page content and structure appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-27T20:57:36.000Z thumbnail image
  3. Check
    29 days ago
    Change Detected
    Summary
    - Added a government funding notice and current operating status information, plus a new version tag v3.2.0. - Removed the term 'Adrenal cortex carcinoma' and the older version tag v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T07:59:11.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.
    Difference
    0.1%
    Check dated 2025-09-29T04:37:58.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the Back to Top link was removed. This shows a version increment and a small UI change.
    Difference
    0.1%
    Check dated 2025-09-14T21:54:18.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-07T19:07:14.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new facility names and locations, as well as the introduction of various medical terms related to cancer and proteins. Notably, several previous terms related to specific cancers and neoplasms have been removed.
    Difference
    5%
    Check dated 2025-08-31T12:21:25.000Z thumbnail image

Stay in the know with updates to Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial page.